Results 101 to 110 of about 51,600 (308)

Immunological phenotype in asthma and its impact on long-term renal outcomes

open access: yesScientific Reports
Asthma is associated with both airway and systemic inflammation as well as non-respiratory adverse outcomes. However, data regarding its impact on long-term renal outcomes is lacking.
Wang Chung Kwok   +6 more
doaj   +1 more source

Subthreshold eosinophilia during food impaction may mask eosinophilic esophagitis: A pediatric case series

open access: yesJPGN Reports, EarlyView.
Abstract To describe the clinical scenario and need for longitudinal follow‐up of pediatric patients presenting with esophageal food impactions (EFIs) regardless of esophageal biopsy eosinophil count. A retrospective chart review was conducted on patients with EFI who underwent endoscopic evaluation from August 2022 to August 2024.
Mark Mahon, Amanda Muir
wiley   +1 more source

A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED [PDF]

open access: yes, 2016
RATIONALE AND OBJECTIVES: Asthma is a heterogeneous disease driven by diverse immunologic and inflammatory mechanisms. We used transcriptomic profiling of airway tissues to help define asthma phenotypes. METHODS: The transcriptome from bronchial biopsies
Adcock, IM   +28 more
core   +4 more sources

Eosinophilic Asthma in Sporthorses

open access: yesJournal of Veterinary Internal Medicine, 2019
In order to identify typical clinical features of eosinophilic asthma insporthorses a retrospective study was performed in 147 Standard-breds and 123 Warmblood sporthorses diagnosed with IAD. Horseswith a clear positive tracheal wash culture or with RAO were excluded.
de Bruijn, Marco   +4 more
openaire   +2 more sources

Dupilumab as an effective therapy for eosinophilic esophagitis in pediatric patients weighing less than 15 kilograms

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Eosinophilic esophagitis (EoE) is a type 2 cytokine‐mediated chronic inflammatory condition leading to esophageal dysfunction. Dupilumab blocks IL‐4 and IL‐13 signaling, which are key inflammatory mediators in EoE and other allergic disorders.
Sindhura Kasturi   +6 more
wiley   +1 more source

New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma [PDF]

open access: yes, 2017
Introduction: Inhaled corticosteroids (ICS) alone or in combination with an inhaled long-acting beta2-agonist (LABA) are the preferred long-term treatment for adults and adolescents with symptomatic asthma.
Thomson, Neil C.
core   +1 more source

Case series: Joubert syndrome and eosinophilic esophagitis

open access: yesJPGN Reports, EarlyView.
Abstract Joubert syndrome (JS) is a rare genetic disorder characterized by developmental abnormalities, particularly in the brainstem and cerebellar vermis, alongside multisystem manifestations such as kidney and liver anomalies, polydactyly, cleft lip or palate, and tongue defects.
Jonathon Schening   +5 more
wiley   +1 more source

Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. [PDF]

open access: yes, 2013
Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects.
Bratt, Jennifer M   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy